Clinical Trial

Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to validate the Lithuanian version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale in a Lithuanian sample. This will be done by comparing results obtained from the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale with results obtained from the Positive and Negative Symptoms Scale, the Montgomery Asberg Depression Rating Scale, and the Montreal Cognitive Assessment test.
Trial Details
NCT Number NCT06278532
Lead Sponsor Lithuanian University of Health Sciences
Conditions Schizophrenia, Negative Symptoms in Schizophrenia, Depressive Symptoms Due to Primary Psychotic Disorder (Diagnosis), Cognitive Deficit
Enrollment 200 participants
Start Date 2023-12-11
Primary Completion 2026-12-11 (estimated)
Study Completion 2026-12-11 (estimated)
Updated on ClinicalTrials.gov 2024-02-26